AP2012006545A0 - Electrochemically activated waterbased solution and use of the solution - Google Patents
Electrochemically activated waterbased solution and use of the solutionInfo
- Publication number
- AP2012006545A0 AP2012006545A0 AP2012006545A AP2012006545A AP2012006545A0 AP 2012006545 A0 AP2012006545 A0 AP 2012006545A0 AP 2012006545 A AP2012006545 A AP 2012006545A AP 2012006545 A AP2012006545 A AP 2012006545A AP 2012006545 A0 AP2012006545 A0 AP 2012006545A0
- Authority
- AP
- ARIPO
- Prior art keywords
- solution
- waterbased
- electrochemically activated
- electrochemically
- activated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/46—Treatment of water, waste water, or sewage by electrochemical methods
- C02F1/461—Treatment of water, waste water, or sewage by electrochemical methods by electrolysis
- C02F1/46104—Devices therefor; Their operating or servicing
- C02F1/4618—Devices therefor; Their operating or servicing for producing "ionised" acidic or basic water
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/46—Treatment of water, waste water, or sewage by electrochemical methods
- C02F1/461—Treatment of water, waste water, or sewage by electrochemical methods by electrolysis
- C02F1/467—Treatment of water, waste water, or sewage by electrochemical methods by electrolysis by electrochemical disinfection; by electrooxydation or by electroreduction
- C02F1/4672—Treatment of water, waste water, or sewage by electrochemical methods by electrolysis by electrochemical disinfection; by electrooxydation or by electroreduction by electrooxydation
- C02F1/4674—Treatment of water, waste water, or sewage by electrochemical methods by electrolysis by electrochemical disinfection; by electrooxydation or by electroreduction by electrooxydation with halogen or compound of halogens, e.g. chlorine, bromine
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2103/00—Nature of the water, waste water, sewage or sludge to be treated
- C02F2103/003—Wastewater from hospitals, laboratories and the like, heavily contaminated by pathogenic microorganisms
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2201/00—Apparatus for treatment of water, waste water or sewage
- C02F2201/46—Apparatus for electrochemical processes
- C02F2201/461—Electrolysis apparatus
- C02F2201/46105—Details relating to the electrolytic devices
- C02F2201/4611—Fluid flow
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2201/00—Apparatus for treatment of water, waste water or sewage
- C02F2201/46—Apparatus for electrochemical processes
- C02F2201/461—Electrolysis apparatus
- C02F2201/46105—Details relating to the electrolytic devices
- C02F2201/46115—Electrolytic cell with membranes or diaphragms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Environmental & Geological Engineering (AREA)
- Water Supply & Treatment (AREA)
- Hydrology & Water Resources (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Electrochemistry (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Water Treatment By Electricity Or Magnetism (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10003555A EP2374762B1 (en) | 2010-03-31 | 2010-03-31 | Assembly and method for generating an electrochemically activated solution |
| EP10008875A EP2422792A1 (en) | 2010-08-26 | 2010-08-26 | Electrochemically activated aqueous solution and use of the solution |
| PCT/EP2011/001635 WO2011120701A1 (en) | 2010-03-31 | 2011-03-31 | Electrochemically activated water-based solution and use of the solution |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AP2012006545A0 true AP2012006545A0 (en) | 2012-10-31 |
Family
ID=44483808
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AP2012006545A AP2012006545A0 (en) | 2010-03-31 | 2011-03-31 | Electrochemically activated waterbased solution and use of the solution |
Country Status (6)
| Country | Link |
|---|---|
| JP (1) | JP2013523666A (en) |
| CN (1) | CN102971262A (en) |
| AP (1) | AP2012006545A0 (en) |
| BR (1) | BR112012024879A2 (en) |
| SG (1) | SG187535A1 (en) |
| WO (1) | WO2011120701A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3424885A1 (en) * | 2011-09-16 | 2019-01-09 | Zurex Pharmagra, LLC | Systems and methods for generating germicidal compositions |
| DE102011055182A1 (en) * | 2011-11-09 | 2013-05-16 | Monopharm Beratungs- Und Handelsgesellschaft Mbh | Anolyte, process for its preparation and its use |
| CN115566228A (en) * | 2022-10-21 | 2023-01-03 | 大连融科储能装备有限公司 | Electrolyte overflow device and method for flow battery system |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6294073B1 (en) * | 1997-10-22 | 2001-09-25 | Chemicoat & Co., Ltd. | Manufacturing method and apparatus of alkaline ionized water |
| RU2157793C1 (en) * | 1999-02-01 | 2000-10-20 | Бахир Витольд Михайлович | Method of preparing disinfecting neutral anolite solution neutral anolite |
| EP1579037A4 (en) * | 2002-03-06 | 2008-02-13 | Univ Georgia Res Found | METHOD AND APPARATUS FOR ELECTROLYSIS OF WATER |
| US20100266710A1 (en) * | 2007-07-26 | 2010-10-21 | Mihran Baronian | Pharmaceutical preparations comprising electrochemically activated hypochlorite solutions |
-
2011
- 2011-03-31 WO PCT/EP2011/001635 patent/WO2011120701A1/en not_active Ceased
- 2011-03-31 AP AP2012006545A patent/AP2012006545A0/en unknown
- 2011-03-31 BR BR112012024879A patent/BR112012024879A2/en not_active IP Right Cessation
- 2011-03-31 JP JP2013501691A patent/JP2013523666A/en not_active Withdrawn
- 2011-03-31 SG SG2012095345A patent/SG187535A1/en unknown
- 2011-03-31 CN CN2011800272458A patent/CN102971262A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2013523666A (en) | 2013-06-17 |
| BR112012024879A2 (en) | 2019-09-24 |
| WO2011120701A8 (en) | 2011-12-01 |
| WO2011120701A1 (en) | 2011-10-06 |
| SG187535A1 (en) | 2013-03-28 |
| CN102971262A (en) | 2013-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL249669A0 (en) | Substituted 5-fluoro-1h-pyrazolopyridines and use thereof | |
| IL221511A (en) | Bisaryl-linked aryltriazolones and their use | |
| IL225713A0 (en) | Cytopheretic cartridge and use thereof | |
| ZA201207574B (en) | Phytocannabinoids in the treatment of cancer | |
| ZA201208173B (en) | Peptices and their use | |
| ZA201300930B (en) | St-246 liquid formulations and methods | |
| ZA201303773B (en) | Compounds and their use | |
| ZA201304012B (en) | Novel compound and medical use thereof | |
| SI2552440T1 (en) | Novel combination and use | |
| GB201011411D0 (en) | Therapeutic compounds and their use | |
| PL2648715T3 (en) | Carnosine-hyaluronic acid mixtures and their use | |
| AP2012006545A0 (en) | Electrochemically activated waterbased solution and use of the solution | |
| GB201718726D0 (en) | Phytocannabinoids in the treatment of cancer | |
| HUP1000688A2 (en) | Use of trifluoro-phthalimides in the treatment of cancer | |
| GB201001370D0 (en) | New compounds and medical uses | |
| GB201001383D0 (en) | New compounds and medical uses | |
| GB201001364D0 (en) | New compounds and medical uses | |
| GB201001376D0 (en) | New compounds and medical uses | |
| GB201000305D0 (en) | Compounds and their use | |
| GB201000309D0 (en) | Compounds and their use | |
| GB201000308D0 (en) | Compounds and their use | |
| GB201000307D0 (en) | Compounds and their use | |
| GB201020848D0 (en) | Compounds and their use | |
| GB201002337D0 (en) | Compounds and their use | |
| GB201005511D0 (en) | Compounds and their use |